Screener
CG Oncology CGON Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Inventory | 1,003 | 1,565 |
| Accounts receivable, net | 417 | 688 |
| Prepaid expenses and other current assets | 19,949 | 15,067 |
| Total current assets | 1,049,647 | 759,475 |
| Property and equipment, net | 14,707 | 15,596 |
| Operating lease right-of-use assets | 5,730 | 3,971 |
| Intangible assets, net | 545 | 575 |
| Goodwill | 10,297 | 10,297 |
Item 1. Financial Statements.
FAQ
- What is CG Oncology's total current assets?
- CG Oncology (CGON) reported total current assets of $1.05B in Q2 2026.
- How has CG Oncology's total current assets changed year-over-year?
- CG Oncology's total current assets increased by 56.0% year-over-year, from $673.03M to $1.05B.
- What is the long-term trend for CG Oncology's total current assets?
- Over 2 years (2023 to 2025), CG Oncology's total current assets has grown at a 97.8% compound annual growth rate (CAGR), from $194.12M to $759.48M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about CG Oncology's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude